Can a DNA Test Tell Us What to Eat?

Today, consumer genetic tests can produce reports on how genetic variants are associated with caffeine metabolism, lactose digestion, levels of certain nutrients, body weight, and other traits. Some companies go further, turning genetic results into recommendations on diet, supplements, or weight management.

The idea sounds logical. If genes influence how the body functions, why not use that information to eat better?

This is where nutrigenetics begins—the science that examines how genetic differences between people may be associated with different responses to dietary components.

But there is a substantial scientific gap between “a gene matters” and “a gene can tell us what to eat.”

A Genetic Test Measures One Thing. Interpretation Is Another.

The first step in genetic testing is relatively straightforward: DNA is analyzed to determine which genetic variants a person carries.

Then comes the more difficult part.

What does that variant mean?

More importantly, is it meaningful enough to justify changing what we eat?

A genetic variant may have a well-established association with a particular biological trait without that association automatically supporting a specific dietary recommendation.

This is why evaluating such tests requires asking at least three distinct questions.

Was the genetic variant measured accurately?

Is there reliable evidence that the variant is associated with the trait of interest?

And does using that information actually improve our decisions?

The three questions may sound similar, but they are not the same.

A Strong Example: LCT/MCM6 and Lactose

The ability to digest lactose in adulthood is a good example of genetic information with a relatively clear biological basis.

Lactose is the sugar in milk. To be absorbed, it must first be broken down by the enzyme lactase, which is encoded by the LCT gene.

In many people, lactase activity declines after childhood. In others, it remains high into adulthood—a trait known as lactase persistence.

Important genetic variants in a regulatory region within the MCM6 gene influence LCT expression and are associated with whether lactase production persists into adulthood. The specific variants—and how informative they are—differ across populations.

In this context, a genetic test can provide meaningful information.

Yet even this comparatively strong example has limits.

A genetic predisposition to reduced lactase activity does not automatically tell us whether someone will experience symptoms after a particular glass of milk. The amount of lactose, the other foods consumed with it, individual sensitivity, and other factors all matter.

In other words: genetic information about lactase activity ≠ a diagnosis of symptomatic lactose intolerance.

It is a subtle but crucial distinction.

CYP1A2 and Caffeine: When Context Matters More

Caffeine offers an even clearer illustration of the complexity of nutrigenetics.

Much of caffeine metabolism is mediated by the CYP1A2 enzyme. Genetic variation in CYP1A2 has been studied in relation to the rate of caffeine metabolism and a range of physiological effects.

The biology is real.

But it does not translate into a simple instruction such as, “Your genotype means two cups of coffee a day.”

Caffeine’s effects depend on the dose, habitual consumption, timing, other factors that influence CYP1A2 activity, and the outcome under consideration—alertness, sleep, athletic performance, or something else.

A genetic variant may be part of the explanation.

It is not the whole explanation.

MTHFR: Real Biochemistry, Many Internet Myths

Few genes illustrate the gap between genuine biology and overinterpretation better than MTHFR.

MTHFR encodes an enzyme with an important role in folate metabolism. The common C677T variant is associated with reduced enzyme activity, particularly in people with the 677 TT genotype.

This is an established biological effect.

Online, however, that finding is often stretched into a much broader claim: that people with this variant cannot use folic acid, should avoid it, or necessarily need a different form of folate.

The evidence does not support such a universal conclusion.

The U.S. Centers for Disease Control and Prevention (CDC) notes that people with common MTHFR variants can process all forms of folate, including folic acid. At the same intake, people with the 677 TT genotype have, on average, approximately 16% lower blood folate concentrations than those with 677 CC; however, folic acid intake has a greater influence on folate levels than genotype itself.

The CDC also notes that there are currently no clinical recommendations for a different intake of folate or folic acid based solely on MTHFR genotype.

Again, the principle is the same: a biological effect ≠ an automatic personalized recommendation.

FTO: A Gene Associated with Weight, Not an “FTO Diet”

FTO is one of the most extensively studied genes in relation to body weight and obesity risk.

Certain FTO variants are reproducibly associated with statistical differences in body weight and obesity risk at the population level.

That does not mean FTO determines any one person’s body weight.

Nor does it mean that we can reliably derive a special “FTO diet” from a single variant.

Body weight is a complex trait shaped by many genetic variants, the food environment, physical activity, sleep, behavior, social factors, and numerous interactions among them.

The genetic contribution is real.

Genetic determinism is not.

How Does One Variant Become an Entire Diet?

That is the question consumers rarely see in a polished genetic report.

In 2026, researchers published a large-scale review of the market for direct-to-consumer nutrigenetic tests. They identified 104 companies and 204 distinct test panels that provided dietary recommendations based on genetic results.

The mean price was approximately US$234.

One finding was particularly notable: only 56 of the 104 companies—54%—publicly disclosed the genes they used to make their dietary recommendations.

Among the companies that provided this information, the researchers identified a total of 3,309 distinct genes used across different categories of dietary recommendations.

This extraordinary diversity does not mean that 3,309 genes are validated tools for determining an individual diet.

Rather, the authors highlight both the difficulty consumers and professionals face in assessing a rapidly evolving, highly variable market and the need to evaluate the evidence behind dietary recommendations.

Association Is the Beginning, Not the End

This is one of the most important dividing lines in nutrigenetics.

Suppose a large study finds an association between a genetic variant and the blood concentration of a particular nutrient.

That is a scientifically interesting association.

But before concluding, “People with this variant should consume more of that nutrient,” we need to answer further questions.

How large is the effect?

Is it replicated across different populations?

Does it depend on diet, age, or other factors?

Most importantly, if we actually change the dietary recommendation based on genotype, does it lead to a better outcome?

That final step is often missing.

The 2026 market review likewise emphasizes the need to evaluate the evidence behind the many genes and dietary recommendations used in direct-to-consumer tests.

Does This Mean Nutrigenetic Tests Are Useless?

No.

That would be just as inaccurate as assuming they can calculate our ideal diet.

For some traits, genetic information rests on a strong and well-understood biological foundation. In other cases, it may contribute only one small piece to a much larger picture. And in still others, the relationship may be scientifically interesting but not yet sufficient to support a practical dietary recommendation.

The better question, then, is not, “Do DNA-based nutrition tests work?”

That question is too broad.

A more useful question is: “Which variant is being tested, what exactly do we know about it, and does the evidence support the specific recommendation we are given?”

How to Read a Genetic Report More Critically

You do not need to be a geneticist to ask a few important questions.

Does the company disclose which genes and variants it uses?

Can we see the scientific sources supporting the specific interpretation?

Does it explain the strength of the association?

Does it distinguish a genetic association from a dietary recommendation supported by evidence?

Does it explain the limitations?

Can we obtain our own genetic data, and do we know how those data are stored and used?

The fact that, in 2026, only slightly more than half of the companies studied publicly disclosed the genes behind their dietary recommendations shows why these questions matter.

Transparency alone does not prove that a test is scientifically valid.

But a lack of transparency makes scientific evaluation far more difficult.

DNA Contains Information. It Does Not Contain a Ready-Made Menu.

Nutrigenetics has a genuine scientific foundation.

Genetic differences can influence enzymes, transport systems, receptors, and other biological processes related to nutrition. In some cases, these relationships are strong enough to be practically informative.

But human nutrition is not determined by a single gene.

Human nutrition is shaped by interactions among many genetic variants, physiology, the food environment, behavior, lifestyle, and numerous other factors.

The value of a genetic test, therefore, is not measured by the number of pages in its report or the number of genes it analyzes.

The more important question is: Can we trace the path from the genetic variant, through the evidence, to the recommendation?

When that path is clear and scientifically supported, genetic information can be useful.

When it is not, a polished personalized report is still only that: a polished personalized report.